Despite management guidelines advocating statin/ezetimibe use in very high cardiovascular risk (CV) conditions, adherence to this therapy is still suboptimal and LDL-C target attainment unsatisfactory. We aimed to investigate the level of adherence to statin/ezetimibe and LDL-C target achievement rates in an unselected very high CV risk population in primary care setting in Italy.

Guglielmi, V., Bellia, A., Pecchioli, S., DELLA MORTE, D., Parretti, D., Cricelli, I., et al. (2017). Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. ATHEROSCLEROSIS, 263, 36-41 [10.1016/j.atherosclerosis.2017.05.018].

Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care

GUGLIELMI, VALERIA;BELLIA, ALFONSO;DELLA MORTE, DAVID;SBRACCIA, PAOLO;LAURO, DAVIDE;
2017

Abstract

Despite management guidelines advocating statin/ezetimibe use in very high cardiovascular risk (CV) conditions, adherence to this therapy is still suboptimal and LDL-C target attainment unsatisfactory. We aimed to investigate the level of adherence to statin/ezetimibe and LDL-C target achievement rates in an unselected very high CV risk population in primary care setting in Italy.
Online ahead of print
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/09 - Medicina Interna
Settore MED/13 - Endocrinologia
English
Con Impact Factor ISI
Adherence to statins; Cholesterol; High cardiovascular risk; Lipid lowering drugs; Low density lipoproteins; Primary care
http://www.sciencedirect.com/science/article/pii/S0021915017302216
Guglielmi, V., Bellia, A., Pecchioli, S., DELLA MORTE, D., Parretti, D., Cricelli, I., et al. (2017). Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. ATHEROSCLEROSIS, 263, 36-41 [10.1016/j.atherosclerosis.2017.05.018].
Guglielmi, V; Bellia, A; Pecchioli, S; DELLA MORTE, D; Parretti, D; Cricelli, I; Medea, G; Sbraccia, P; Lauro, D; Cricelli, C; Lapi, F
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Adherence Statins Atherosclerosis 2017.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 487.33 kB
Formato Adobe PDF
487.33 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/186346
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 45
social impact